Importance of Pediatric Studies in SARS-CoV-2 Vaccine Development
| Autor: | Nicole Passerrello, Dhara D. Shah, Sylvia Stoffella, Rachel Meyers, Jared Cash, JoEllen Weilnau, Erin Wilson, Jennifer E Girotto, Jamie Legaspi, Alyssa Wu |
|---|---|
| Rok vydání: | 2021 |
| Předmět: |
2019-20 coronavirus outbreak
medicine.medical_specialty Opinion Coronavirus disease 2019 (COVID-19) business.industry Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Pharmacy Vaccination Pediatrics Perinatology and Child Health medicine Pharmacology (medical) Intensive care medicine business Pediatric population |
| Zdroj: | J Pediatr Pharmacol Ther |
| ISSN: | 1551-6776 |
| Popis: | Vaccination efforts against COVID-19 must include the pediatric population, not only to protect children and their families from the virus, but also to support a safe return to in-person schooling. Given the novel methodologies and targets used in the COVID-19 vaccines and the potential for multisystem inflammatory syndrome-children, it is insufficient to extrapolate safety and efficacy data between different vaccine candidates or from adult studies. Adequate enrollment in pediatric studies for COVID-19 vaccines is crucial. The Pediatric Pharmacy Association supports continued research, surveillance, and transparency for COVID-19 vaccines in the pediatric population, including those younger than 12 years of age. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|